Gerard De Jong

1.2k total citations
19 papers, 592 citations indexed

About

Gerard De Jong is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Gerard De Jong has authored 19 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Physiology and 5 papers in Clinical Biochemistry. Recurrent topics in Gerard De Jong's work include Mitochondrial Function and Pathology (5 papers), Metabolism and Genetic Disorders (5 papers) and Iron Metabolism and Disorders (5 papers). Gerard De Jong is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), Metabolism and Genetic Disorders (5 papers) and Iron Metabolism and Disorders (5 papers). Gerard De Jong collaborates with scholars based in Australia, Netherlands and Austria. Gerard De Jong's co-authors include H.G. van Eijk, Timothy Fazio, Wendy Kelso, Mark Walterfang, Sarah Farrand, Arnold G. Vulto, Arnold Reuser, Wim Hop, Pieter A. van Doorn and Otto P. van Diggelen and has published in prestigious journals such as Annals of Neurology, European Journal of Immunology and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Gerard De Jong

19 papers receiving 565 citations

Peers

Gerard De Jong
Janine Reunert Germany
Roberta Taurisano Italy
Hélène Ogier France
Philip P. Dembure United States
María Josep Coll Spain
Dimitar Gavrilov United States
Giulia Polo Italy
Ali Dursun Türkiye
Zuhair N. Al‐Hassnan Saudi Arabia
Ana Marcão Portugal
Janine Reunert Germany
Gerard De Jong
Citations per year, relative to Gerard De Jong Gerard De Jong (= 1×) peers Janine Reunert

Countries citing papers authored by Gerard De Jong

Since Specialization
Citations

This map shows the geographic impact of Gerard De Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard De Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard De Jong more than expected).

Fields of papers citing papers by Gerard De Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard De Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard De Jong. The network helps show where Gerard De Jong may publish in the future.

Co-authorship network of co-authors of Gerard De Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard De Jong. A scholar is included among the top collaborators of Gerard De Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard De Jong. Gerard De Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Selvanathan, Arthavan, Gerard De Jong, Drago Bratkovic, et al.. (2022). A serendipitous journey to a promoter variant: The c.‐106C>A variant and its role in late‐onset ornithine transcarbamylase deficiency. JIMD Reports. 63(4). 271–275. 3 indexed citations
2.
Jong, Gerard De, et al.. (2022). Novel chorioretinal findings in two siblings with mucopolysaccharidosis type VI. Ophthalmic Genetics. 43(5). 693–698. 3 indexed citations
3.
Kelso, Wendy, Charles B. Malpas, Toby Winton‐Brown, et al.. (2021). The effect of improved dietary control on cognitive and psychiatric functioning in adults with phenylketonuria: the ReDAPT study. Orphanet Journal of Rare Diseases. 16(1). 35–35. 24 indexed citations
4.
Ruddle, Jonathan B., et al.. (2021). Expanding the phenotype of mucopolysaccharidosis type II retinopathy. Ophthalmic Genetics. 42(5). 631–636. 4 indexed citations
5.
Gaillard, Frank, et al.. (2020). OCD symptoms in succinic semialdehyde dehydrogenase (SSADH) deficiency: a case report. BMC Psychiatry. 20(1). 395–395. 4 indexed citations
6.
Kelso, Wendy, et al.. (2019). Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments. Frontiers in Psychiatry. 10. 561–561. 96 indexed citations
7.
Wong, Rosemary, et al.. (2018). Mitochondrial disease: an uncommon but important cause of diabetes mellitus. Endocrinology Diabetes and Metabolism Case Reports. 2018. 25 indexed citations
8.
Mack, Heather G., R. C. Andrew Symons, & Gerard De Jong. (2017). Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy. American Journal of Ophthalmology Case Reports. 9. 1–6. 11 indexed citations
9.
Anstey, James, et al.. (2015). Initial presentation of a urea cycle disorder in adulthood: an under‐recognised cause of severe neurological dysfunction. The Medical Journal of Australia. 203(11). 445–447. 3 indexed citations
10.
Pietrangelo, Antonello, Elena Corradini, Francesca Ferrara, et al.. (2006). Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease. Blood Cells Molecules and Diseases. 37(3). 192–196. 40 indexed citations
11.
Alizadeh, Behrooz Z., Omer T. Njajou, Jeanine J. Houwing‐Duistermaat, et al.. (2004). Does bilirubin protect against hemochromatosis gene (HFE) related mortality?. American Journal of Medical Genetics Part A. 129A(1). 39–43. 8 indexed citations
12.
Winkel, Léon P. F., Johanna M. P. van den Hout, Willem F. Arts, et al.. (2004). Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐up. Annals of Neurology. 55(4). 495–502. 161 indexed citations
13.
Njajou, Omer T., Gerard De Jong, Bianca Berghuis, et al.. (2002). Dominant Hemochromatosis Due to N144H Mutation of SLC11A3: Clinical and Biological Characteristics. Blood Cells Molecules and Diseases. 29(3). 439–443. 31 indexed citations
14.
Kricek, Franz, et al.. (1997). Suppression of in vivo IgE and tissue IL-4 mRNA induction by SDZ 280.636, a synthetic muramyl dipeptide derivative. Immunopharmacology. 36(1). 27–39. 6 indexed citations
15.
Smit, Maarten H. de, et al.. (1996). Isolation, renaturation and partial characterization of recombinant human transferrin and its half molecules from escherichia coli. The International Journal of Biochemistry & Cell Biology. 28(9). 975–982. 18 indexed citations
16.
Smit, Maarten H. de, et al.. (1995). Optimized bacterial production of nonglycosylated human transferrin and its half-molecules. The International Journal of Biochemistry & Cell Biology. 27(8). 839–850. 15 indexed citations
17.
18.
Jong, Gerard De, et al.. (1992). Carbohydrate analysis of transferrin subfractions isolated by preparative isoelectric focusing in immobilized pH gradients. Electrophoresis. 13(1). 225–228. 18 indexed citations
19.
Jong, Gerard De & H.G. van Eijk. (1988). Microheterogeneity of human serum transferrin: A biological phenomenon studied by isoelectric focusing in immobilized pH gradients. Electrophoresis. 9(9). 589–598. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janine Reunert Breakdown of academic impact, for papers by Roberta Taurisano Breakdown of academic impact, for papers by Hélène Ogier Breakdown of academic impact, for papers by Philip P. Dembure Breakdown of academic impact, for papers by María Josep Coll Breakdown of academic impact, for papers by Dimitar Gavrilov Breakdown of academic impact, for papers by Giulia Polo Breakdown of academic impact, for papers by Ali Dursun Breakdown of academic impact, for papers by Zuhair N. Al‐Hassnan Breakdown of academic impact, for papers by Ana Marcão
Rankless by CCL
2026